BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35763788)

  • 1. Cu
    Zhang X; Wang S; Tang K; Pan W; Xu H; Li Y; Gao Y; Li N; Tang B
    ACS Appl Mater Interfaces; 2022 Jul; 14(27):30618-30625. PubMed ID: 35763788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-Coordinated Covalent Organic Framework Produced a Robust Fenton-Like Effect Inducing Immunogenic Cell Death of Tumors.
    Li T; Wang D; Meng M; Yang Z; Luo Z; Li Z; Li F; Liu C; Hao K; Pang X; Tian H; Chen X
    Macromol Rapid Commun; 2023 Jun; 44(11):e2200929. PubMed ID: 36840703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Dimensional Covalent Organic Frameworks with Cross-Linked Pores for Efficient Cancer Immunotherapy.
    Zhang L; Yang LL; Wan SC; Yang QC; Xiao Y; Deng H; Sun ZJ
    Nano Lett; 2021 Oct; 21(19):7979-7988. PubMed ID: 34525805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent Organic Framework-Based Nanocomposite for Synergetic Photo-, Chemodynamic-, and Immunotherapies.
    Liu S; Zhou Y; Hu C; Cai L; Pang M
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43456-43465. PubMed ID: 32880166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
    Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A covalent organic framework-based nanoagent for H
    Feng J; Ren WX; Kong F; Dong YB
    Chem Commun (Camb); 2021 Jul; 57(59):7240-7243. PubMed ID: 34190264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
    Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation.
    Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R
    ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained By Employing a Nano-MOF with Cu
    Zhang W; Lu J; Gao X; Li P; Zhang W; Ma Y; Wang H; Tang B
    Angew Chem Int Ed Engl; 2018 Apr; 57(18):4891-4896. PubMed ID: 29451722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reactive oxygen species-responsive covalent organic framework for tumor combination therapy.
    Li WY; Kan JL; Wan JJ; Li YA; Song T; Wang B; Guan Q; Zhou LL; Dong YB
    Chem Commun (Camb); 2023 May; 59(36):5423-5426. PubMed ID: 37066608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monodispersed CuSe Sensitized Covalent Organic Framework Photosensitizer with an Enhanced Photodynamic and Photothermal Effect for Cancer Therapy.
    Hu C; Zhang Z; Liu S; Liu X; Pang M
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):23072-23082. PubMed ID: 31252509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A facile method for the synthesis of copper-cysteamine nanoparticles and study of ROS production for cancer treatment.
    Pandey NK; Chudal L; Phan J; Lin L; Johnson O; Xing M; Liu JP; Li H; Huang X; Shu Y; Chen W
    J Mater Chem B; 2019 Nov; 7(42):6630-6642. PubMed ID: 31591609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Metal-Organic Framework Hybrid AIEgens with Tumor-Activated Accumulation and Emission for the Image-Guided GSH Depletion ROS Therapy.
    Dong MJ; Li W; Xiang Q; Tan Y; Xing X; Wu C; Dong H; Zhang X
    ACS Appl Mater Interfaces; 2022 Jul; 14(26):29599-29612. PubMed ID: 35737456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-Infrared Light-Enhanced Generation of Hydroxyl Radical for Cancer Immunotherapy.
    Zhang Q; Li Y; Jiang C; Sun W; Tao J; Lu L
    Adv Healthc Mater; 2023 Nov; 12(28):e2301502. PubMed ID: 37409492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal-clearable ultrasmall covalent organic framework nanodots as photodynamic agents for effective cancer therapy.
    Zhang Y; Zhang L; Wang Z; Wang F; Kang L; Cao F; Dong K; Ren J; Qu X
    Biomaterials; 2019 Dec; 223():119462. PubMed ID: 31491599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal-Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells.
    Liu Y; Niu R; Zhang X; Zhang B; Chen X; Guo J; Song S; Wang Y; Zhang H; Zhao Y
    ACS Nano; 2024 May; 18(19):12386-12400. PubMed ID: 38699808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief.
    Liu C; Wang D; Zhang S; Cheng Y; Yang F; Xing Y; Xu T; Dong H; Zhang X
    ACS Nano; 2019 Apr; 13(4):4267-4277. PubMed ID: 30901515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazine-based covalent organic frameworks for photodynamic inactivation of bacteria as type-II photosensitizers.
    Liu T; Hu X; Wang Y; Meng L; Zhou Y; Zhang J; Chen M; Zhang X
    J Photochem Photobiol B; 2017 Oct; 175():156-162. PubMed ID: 28888168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-Based Metal-Organic Framework Enables ROS Amplification and Drug Potency Activation.
    Zuo J; Hao S; Li W; Huang H; Liu M; Guo H
    Langmuir; 2023 Jun; 39(23):8008-8021. PubMed ID: 37234046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.